4.3 Editorial Material

Targeting ROS1 rearrangements in non-small cell lung cancer with crizotinib and other kinase inhibitors

Journal

TRANSLATIONAL CANCER RESEARCH
Volume 7, Issue -, Pages S779-S786

Publisher

AME PUBL CO
DOI: 10.21037/tcr.2018.08.11

Keywords

-

Categories

Funding

  1. National Institutes of Health (NIH)/National Cancer Institute (NCI) [R37CA218707]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available